Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations

Given the tubal origin of high-grade serous ovarian cancer (HGSC), we sought to investigate intrauterine lavage (IUL) as a novel method of biomarker detection. IUL and serum samples were collected from patients with HGSC or benign pathology. Although CA-125 and HE4 concentrations were significantly...

Full description

Bibliographic Details
Main Authors: Tiffany Y. Sia, Zvi Yaari, Ron Feiner, Evan Smith, Arnaud Da Cruz Paula, Pier Selenica, Sital Doddi, Dennis S. Chi, Nadeem R. Abu-Rustum, Douglas A. Levine, Britta Weigelt, Martin Fleisher, Lakshmi V. Ramanathan, Daniel A. Heller, Kara Long Roche
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578924000092
_version_ 1827345979605516288
author Tiffany Y. Sia
Zvi Yaari
Ron Feiner
Evan Smith
Arnaud Da Cruz Paula
Pier Selenica
Sital Doddi
Dennis S. Chi
Nadeem R. Abu-Rustum
Douglas A. Levine
Britta Weigelt
Martin Fleisher
Lakshmi V. Ramanathan
Daniel A. Heller
Kara Long Roche
author_facet Tiffany Y. Sia
Zvi Yaari
Ron Feiner
Evan Smith
Arnaud Da Cruz Paula
Pier Selenica
Sital Doddi
Dennis S. Chi
Nadeem R. Abu-Rustum
Douglas A. Levine
Britta Weigelt
Martin Fleisher
Lakshmi V. Ramanathan
Daniel A. Heller
Kara Long Roche
author_sort Tiffany Y. Sia
collection DOAJ
description Given the tubal origin of high-grade serous ovarian cancer (HGSC), we sought to investigate intrauterine lavage (IUL) as a novel method of biomarker detection. IUL and serum samples were collected from patients with HGSC or benign pathology. Although CA-125 and HE4 concentrations were significantly higher in IUL samples compared to serum, they were similar between IUL samples from patients with HGSC vs benign conditions. In contrast, CA-125 and HE4 serum concentrations differed between HGSC and benign pathology (P =.002 for both). IUL and tumor samples from patients with HGSC were subjected to targeted panel sequencing and droplet digital PCR (ddPCR). Tumor mutations were found in 75 % of matched IUL samples. Serum CA-125 and HE4 biomarker levels allowed for better differentiation of HGSC and benign pathology compared to IUL samples. We believe using IUL for early detection of HGSC requires optimization, and current strategies should focus on prevention until early detection strategies improve.
first_indexed 2024-03-07T23:21:31Z
format Article
id doaj.art-0ec9b8149c314a47adc99948d4bc2357
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-03-07T23:21:31Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-0ec9b8149c314a47adc99948d4bc23572024-02-21T05:28:50ZengElsevierGynecologic Oncology Reports2352-57892024-02-0151101330Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulationsTiffany Y. Sia0Zvi Yaari1Ron Feiner2Evan Smith3Arnaud Da Cruz Paula4Pier Selenica5Sital Doddi6Dennis S. Chi7Nadeem R. Abu-Rustum8Douglas A. Levine9Britta Weigelt10Martin Fleisher11Lakshmi V. Ramanathan12Daniel A. Heller13Kara Long Roche14Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USASchool of Pharmacy, Department of Medicine, Hebrew University of Jerusalem, IsraelDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAi3S Instituto de Investigação e Inovação em Saúde, Porto, Portugal; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USADepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USAMerck Research Laboratories, Rahway, NJ, USADepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Pharmacology, Weill Cornell Medical College, Cornell University, New York, NY, USADepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of OB/GYN, Weill Cornell Medical College, New York, NY, USA; Corresponding author at: Gynecologic Oncology Fellowship Program, Section of Ovarian Cancer Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Howard 13, New York, NY 10065, USA.Given the tubal origin of high-grade serous ovarian cancer (HGSC), we sought to investigate intrauterine lavage (IUL) as a novel method of biomarker detection. IUL and serum samples were collected from patients with HGSC or benign pathology. Although CA-125 and HE4 concentrations were significantly higher in IUL samples compared to serum, they were similar between IUL samples from patients with HGSC vs benign conditions. In contrast, CA-125 and HE4 serum concentrations differed between HGSC and benign pathology (P =.002 for both). IUL and tumor samples from patients with HGSC were subjected to targeted panel sequencing and droplet digital PCR (ddPCR). Tumor mutations were found in 75 % of matched IUL samples. Serum CA-125 and HE4 biomarker levels allowed for better differentiation of HGSC and benign pathology compared to IUL samples. We believe using IUL for early detection of HGSC requires optimization, and current strategies should focus on prevention until early detection strategies improve.http://www.sciencedirect.com/science/article/pii/S2352578924000092Ovarian cancerIntrauterine lavageEarly detection
spellingShingle Tiffany Y. Sia
Zvi Yaari
Ron Feiner
Evan Smith
Arnaud Da Cruz Paula
Pier Selenica
Sital Doddi
Dennis S. Chi
Nadeem R. Abu-Rustum
Douglas A. Levine
Britta Weigelt
Martin Fleisher
Lakshmi V. Ramanathan
Daniel A. Heller
Kara Long Roche
Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
Gynecologic Oncology Reports
Ovarian cancer
Intrauterine lavage
Early detection
title Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
title_full Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
title_fullStr Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
title_full_unstemmed Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
title_short Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations
title_sort uterine washings as a novel method for early detection of ovarian cancer trials and tribulations
topic Ovarian cancer
Intrauterine lavage
Early detection
url http://www.sciencedirect.com/science/article/pii/S2352578924000092
work_keys_str_mv AT tiffanyysia uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT zviyaari uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT ronfeiner uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT evansmith uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT arnauddacruzpaula uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT pierselenica uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT sitaldoddi uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT dennisschi uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT nadeemraburustum uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT douglasalevine uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT brittaweigelt uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT martinfleisher uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT lakshmivramanathan uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT danielaheller uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations
AT karalongroche uterinewashingsasanovelmethodforearlydetectionofovariancancertrialsandtribulations